Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan monotherapy for refractory or relapsed hepatoblastoma in children
2005-002925-29Phase 2Completed
- Sponsor
- University Children’s Hospital
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of irinotecan in hepatoblastoma, sponsored by University Children’s Hospital. Primary endpoint: Response rate (best overall response). Started Aug 2005; status: completed.
02
Drugs
irinotecan
03
Conditions
hepatoblastoma
Beyond the preview
Go deeper on 2005-002925-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002925-29.